Global research trends on Chinese patent drugs inducing programmed cell death in cancer: a bibliometric analysis (1998–2024)
Abstract Background Chinese patent drugs, standardized formulations rooted in traditional Chinese medicine, have gained attention for their potential to induce programmed cell death (PCD) in cancer cells. Emerging evidence suggests that these formulations may affect multiple PCD pathways, including...
Saved in:
| Main Authors: | Min Song, Chunyan Teng, Xiaodong Zheng, Shizhen Tan, Yipeng Guo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02913-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of programmed cell death in renal cancer: a bibliometric perspective (1998–2024)
by: Liang Hong, et al.
Published: (2025-05-01) -
Influencing factors, evolution, and strategies for improving the quality of traditional Chinese medicine patents: an empirical study based on patent invalidation cases
by: Xin Li
Published: (2024-12-01) -
Case report: Accidental aconitine poisoning caused by the inappropriate use of a type of Chinese patent medicine
by: Ruikai Shang, et al.
Published: (2025-01-01) -
Traditional Chinese medicine for cardiovascular disease: efficacy and safety
by: Youwei Lin, et al.
Published: (2024-12-01) -
Clinical research report on Chinese patent medicines and classic traditional Chinese medicine prescriptions (2023)
by: Xiaolei Wu, et al.
Published: (2025-06-01)